Ludwine Messiaen
- Neurology top 0.5%
- Neurofibromatosis and Schwannoma Cases 65
- Neuroblastoma Research and Treatments 13
- Rheumatology top 1%
- Soft tissue tumor case studies 14
-
- Genetic factors in colorectal cancer 10
- Genetics top 2%
- Genomic variations and chromosomal abnormalities 21
- Molecular Biology top 5%
- Chromatin Remodeling and Cancer 15
-
- Sarcoma Diagnosis and Treatment 14
-
- Chromosomal and Genetic Variations 11
- Co-authors
- Tom CallensKatharina WimmerEric LegiusAnne De PaepeIna VandenbrouckeKathleen ClaesFrank SpelemanHilde Brems
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Ludwine Messiaen
142 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 116
- Neurology 2.3k
- Rheumatology 784
- Pathology and Forensic Medicine 661
- Genetics 932
- Molecular Biology 2.2k
Countries citing papers authored by Ludwine Messiaen
This map shows the geographic impact of Ludwine Messiaen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludwine Messiaen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludwine Messiaen more than expected).
Fields of papers citing papers by Ludwine Messiaen
This network shows the impact of papers produced by Ludwine Messiaen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludwine Messiaen. The network helps show where Ludwine Messiaen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ludwine Messiaen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2019 | 7 | |
| 4 | 2017 | 22 | |
| 5 | 2012 | 184 | |
| 6 | 2012 | 69 | |
| 7 | 2011 | 57 | |
| 8 | 2009 | 92 | |
| 9 | Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association (vol 69, pg 7393, 2009) | 2009 | 4 |
| 10 | Loss of heterozygosity at 17p13.3 and 17p13.1 loci is associated with poor survival of African Americans with colorectal adenocarcinomas | 2007 | 1 |
| 11 | Rabphillin-3A-Like gene is a candidate tumor suppressor in colorectal adenocarcinoma | 2007 | 1 |
| 12 | 2007 | 97 | |
| 13 | 2006 | 107 | |
| 14 | 2004 | 163 | |
| 15 | 2004 | 42 | |
| 16 | BRCA1/2 mutation spectrum and frequencies in Belgian breast/ovarian cancer families | 2003 | 0 |
| 17 | Multicenter validation of a new reverse hybridization assay for CFTR mutation analysis | 2002 | 1 |
| 18 | 2001 | 14 | |
| 19 | Identification and characterisation of a founder mutation in the Belgian breast/ovarian cancer population | 2000 | 2 |
| 20 | 1998 | 32 |
About Ludwine Messiaen
Ludwine Messiaen is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine, having authored 145 papers that have together received 5.0k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (65 papers), Genomic variations and chromosomal abnormalities (21 papers), Chromatin Remodeling and Cancer (15 papers), Soft tissue tumor case studies (14 papers), Sarcoma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (13 papers), Chromosomal and Genetic Variations (11 papers) and Genetic factors in colorectal cancer (10 papers). The work is most often cited by research in Neurology (2.3k citations), Rheumatology (784 citations) and Pathology and Forensic Medicine (661 citations). Ludwine Messiaen has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Tom Callens, Katharina Wimmer, Eric Legius, Anne De Paepe, Ina Vandenbroucke, Kathleen Claes, Frank Speleman, Hilde Brems, Geert Mortier and Ophélia Maertens. Their work appears in journals such as Cell, JAMA and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.